Menu
Search
|

Menu

Close
X

Sumitomo Dainippon Pharma Co Ltd 4506.T (Tokyo Stock Exchange)

1,611.00 JPY
+5.00 (+0.31%)
As of 6:00 AM GMT
chart
Previous Close 1,606.00
Open 1,613.00
Volume 1,290,100
3m Avg Volume 1,614,265
Today’s High 1,620.00
Today’s Low 1,603.00
52 Week High 2,069.00
52 Week Low 1,397.00
Shares Outstanding (mil) 397.90
Market Capitalization (mil) 604,410.31
Forward P/E 17.23
Dividend (Yield %) 11.00 ( 1.18 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.56 Mean rating from 9 analysts

KEY STATS

Revenue (mm, JPY)
FY18
364,121
FY17
411,638
FY16
403,206
FY15
371,370
EPS (JPY)
FY18
127.337
FY17
72.970
FY16
62.162
FY15
38.879
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.23
32.90
Price to Sales (TTM)
vs sector
1.42
5.77
Price to Book (MRQ)
vs sector
1.28
5.41
Price to Cash Flow (TTM)
vs sector
11.27
23.42
Total Debt to Equity (MRQ)
vs sector
14.40
16.52
LT Debt to Equity (MRQ)
vs sector
2.12
12.22
Return on Investment (TTM)
vs sector
6.47
14.43
Return on Equity (TTM)
vs sector
7.80
16.13

EXECUTIVE LEADERSHIP

Hiroshi Nomura
Senior Managing Executive Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Hitoshi Odagiri
Managing Executive Officer, Chief Director of Sales, Director, Since 2016
Salary: --
Bonus: --
Yoshiharu Ikeda
Managing Executive Officer, Chief Director of Production, Since 2017
Salary: --
Bonus: --
Kazuo Koshiya
Managing Executive Officer, Since 2017
Salary: --
Bonus: --
Nobuhiko Tamura
Managing Executive Officer, Chairman & Chief Executive Officer of Subsidiary, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2-6-8, Dosho-machi, Chuo-ku
OSAKA-SHI   OSK   541-0045

Phone: +816.62035321

Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Japan segment manufactures and sells ethical and general use drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other Overseas division is involved in the development of its products in Europe. The Company is also engaged in the manufacture, purchase, sale and supply of food materials and additives, chemical products, veterinary drugs, diagnostic products and inspection services of clinical pathology for animal, the manufacture of extracts, as well as the storage, delivery and clinical inspection of drugs.

SPONSORED STORIES